Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: LCR001
MIFTS: 33

Lacrimal Duct Obstruction

Categories: Eye diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Lacrimal Duct Obstruction

About this section

MalaCards integrated aliases for Lacrimal Duct Obstruction:

Name: Lacrimal Duct Obstruction 12 44 15
Obstruction of Lacrimal Canaliculus 12
Obstruction of Lacrimal Ducts 12
Blocked Lacrimal Canaliculus 12

Classifications:

MalaCards categories:
Anatomical: Eye diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:13929
MeSH 44 D007767
NCIt 50 C34757
SNOMED-CT 68 95769009
UMLS 73 C0022906
Sources

Summaries for Lacrimal Duct Obstruction

About this section
MalaCards based summary : Lacrimal Duct Obstruction, also known as obstruction of lacrimal canaliculus, is related to branchiooculofacial syndrome and ectodermal dysplasia 4, hair/nail type. An important gene associated with Lacrimal Duct Obstruction is DCXR (Dicarbonyl And L-Xylulose Reductase), and among its related pathways/superpathways is Hypothetical Craniofacial Development Pathway. The drugs Pseudoephedrine and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include eye, and related phenotypes are behavior/neurological and mortality/aging

Sources

Related Diseases for Lacrimal Duct Obstruction

About this section

Diseases related to Lacrimal Duct Obstruction via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 25)
# Related Disease Score Top Affiliating Genes
1 branchiooculofacial syndrome 31.9 EYA1 SIX5 TFAP2A
2 ectodermal dysplasia 4, hair/nail type 30.1 HOXC13 KRT85
3 dacryocystitis 30.1 DCXR OPTN
4 chronic dacryocystitis 29.9 DCXR PGRMC1
5 ectodermal dysplasia 29.8 HOXC13 KRT85 TP63
6 growth retardation, deafness, femoral epiphyseal dysplasia, and lacrimal duct obstruction 12.4
7 blepharonasofacial malformation syndrome 11.4
8 lacrimal duct defect 11.4
9 deafness, epiphyseal dysplasia, short stature 11.4
10 acute inflammation of lacrimal passage 10.1 DCXR OPTN
11 excessive tearing 10.1 DCXR OPTN
12 branchiootorenal syndrome 1 10.1 EYA1 SIX1
13 deafness, autosomal dominant 23 10.1 EYA1 SIX1
14 ear malformation 10.1 EYA1 TFAP2A
15 hair disease 10.0 HOXC13 KRT85
16 esotropia 10.0 OPTN TFAP2A
17 exophthalmos 10.0 OPTN TGFB1
18 deafness, autosomal dominant 10 10.0 EYA1 SIX1 SIX5
19 amblyopia 10.0 OPTN TFAP2A
20 branchiootorenal syndrome 10.0 EYA1 SIX1 SIX5
21 branchiootic syndrome 10.0 EYA1 SIX1 SIX5
22 dacryoadenitis 9.9
23 chronic inflammation of lacrimal passage 9.9 DCXR PGRMC1
24 eaf 9.9
25 renal hypodysplasia/aplasia 1 9.9 EYA1 SIX5

Graphical network of the top 20 diseases related to Lacrimal Duct Obstruction:



Diseases related to Lacrimal Duct Obstruction
Sources

Symptoms & Phenotypes for Lacrimal Duct Obstruction

About this section

MGI Mouse Phenotypes related to Lacrimal Duct Obstruction:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.02 EYA1 HOXC13 PGRMC1 SIX1 TFAP2A TGFB1
2 mortality/aging MP:0010768 9.97 EYA1 HOXC13 OPTN PGRMC1 SIX1 TFAP2A
3 endocrine/exocrine gland MP:0005379 9.95 EYA1 PGRMC1 SIX1 SIX5 TFAP2A TGFB1
4 craniofacial MP:0005382 9.93 EYA1 HOXC13 SIX1 TFAP2A TGFB1 TP63
5 digestive/alimentary MP:0005381 9.91 EYA1 HOXC13 SIX1 TFAP2A TGFB1 TP63
6 muscle MP:0005369 9.72 EYA1 SIX1 SIX5 TGFB1 TP63
7 respiratory system MP:0005388 9.65 EYA1 SIX1 TFAP2A TGFB1 TP63
8 skeleton MP:0005390 9.63 EYA1 HOXC13 SIX1 TFAP2A TGFB1 TP63
9 vision/eye MP:0005391 9.17 EYA1 HOXC13 SIX1 SIX5 TFAP2A TGFB1
10 taste/olfaction MP:0005394 9.13 PGRMC1 SIX1 TP63
Sources

Drugs & Therapeutics for Lacrimal Duct Obstruction

About this section

Drugs for Lacrimal Duct Obstruction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 7)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Pseudoephedrine Approved Phase 1, Phase 2 90-82-4 7028
2
Lidocaine Approved, Vet_approved Phase 1, Phase 2 137-58-6 3676
3
Tetracaine Approved, Vet_approved Phase 1, Phase 2 94-24-6 5411
4
Ephedrine Approved Phase 1, Phase 2 299-42-3 9294
5 Anesthetics Phase 1, Phase 2
6 Ether Not Applicable
7 Mitomycins Not Applicable

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Comparative Study of Two Endoscopic Operations for Lacrimal Duct Obstruction Completed NCT02636257 Phase 1, Phase 2
2 Analysis of 86 Dacryoliths at the University Hospital Ostrava Completed NCT01826734
3 Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children Recruiting NCT02851641
4 Endoscopic Dacryocystorhinostomy Prospective Research Active, not recruiting NCT00571129 Not Applicable
5 A Feasibility Study to Develop a Protocol for Functional Lacrimal Magnetic Resonance Imaging Not yet recruiting NCT03411889 Not Applicable

Search NIH Clinical Center for Lacrimal Duct Obstruction

Cochrane evidence based reviews: lacrimal duct obstruction

Sources

Genetic Tests for Lacrimal Duct Obstruction

About this section
Sources

Anatomical Context for Lacrimal Duct Obstruction

About this section

MalaCards organs/tissues related to Lacrimal Duct Obstruction:

41
Eye
Sources

Publications for Lacrimal Duct Obstruction

About this section

Articles related to Lacrimal Duct Obstruction:

(show all 17)
# Title Authors Year
1
Cytokine Profiles of Tear Fluid From Patients With Pediatric Lacrimal Duct Obstruction. ( 28114586 )
2017
2
Intervention using a novel biodegradable hollow stent containing polylactic acid-polyprolactone-polyethylene glycol complexes against lacrimal duct obstruction disease. ( 28570687 )
2017
3
An insertion mutation in HOXC13 underlies pure hair and nail ectodermal dysplasia with lacrimal duct obstruction. ( 29278420 )
2017
4
Factors Associated with the Efficacy of Probing for Adult Patients with Lacrimal Duct Obstruction. ( 27015237 )
2016
5
High-resolution dacryoendoscopy for observation for pediatric lacrimal duct obstruction. ( 29503884 )
2016
6
Direct endoscopic probing for congenital lacrimal duct obstruction. ( 23566023 )
2013
7
Relationship between frequent swimming pool use and lacrimal duct obstruction. ( 24112783 )
2013
8
Transcanalicular approach to adult lacrimal duct obstruction: a review of instruments and methods. ( 19320304 )
2009
9
Uncommon presentation of congenital lacrimal duct obstruction a case report of congenital amniontocele. ( 22400096 )
2007
10
Eosinophilic angiocentric fibrosis: an unusual entity producing complete lacrimal duct obstruction. ( 16754230 )
2006
11
The clinical value of dacryoscintigraphy in the selection of surgical approach for patients with functional lacrimal duct obstruction. ( 16248384 )
2005
12
Diagnostic Ophthalmology. Left dacryocystitis with naso-lacrimal duct obstruction. ( 15600163 )
2004
13
Dilatation and stenting for naso-lacrimal duct obstruction: a pilot project. ( 10551300 )
1999
14
Bacteriology of lacrimal duct obstruction in adults. ( 9135406 )
1997
15
Silicone intubation for the treatment of congenital lacrimal duct obstruction: successful results removing the tubes after six weeks. ( 3211482 )
1988
16
CORTICOSTEROIDS AND FIBROLYSIN IN THE PREVENTION OF LACRIMAL DUCT OBSTRUCTION. ( 18170750 )
1962
17
The management of lacrimal duct obstruction. ( 14824621 )
1951
Sources

Variations for Lacrimal Duct Obstruction

About this section
Sources

Expression for Lacrimal Duct Obstruction

About this section
Search GEO for disease gene expression data for Lacrimal Duct Obstruction.
Sources

Pathways for Lacrimal Duct Obstruction

About this section

Pathways related to Lacrimal Duct Obstruction according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Hypothetical Craniofacial Development Pathway 1
9.53 TFAP2A TP63
Sources

GO Terms for Lacrimal Duct Obstruction

About this section

Cellular components related to Lacrimal Duct Obstruction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nucleus GO:0005634 9.28 DCXR EYA1 HOXC13 OPTN SIX1 SIX5

Biological processes related to Lacrimal Duct Obstruction according to GeneCards Suite gene sharing:

(show all 29)
# Name GO ID Score Top Affiliating Genes
1 multicellular organism development GO:0007275 9.97 EYA1 HOXC13 SIX1 SIX5 TP63
2 negative regulation of transcription by RNA polymerase II GO:0000122 9.94 SIX1 TFAP2A TGFB1 TP63
3 positive regulation of transcription, DNA-templated GO:0045893 9.85 EYA1 SIX1 TFAP2A TGFB1 TP63
4 transcription by RNA polymerase II GO:0006366 9.83 HOXC13 SIX1 SIX5 TFAP2A TP63
5 negative regulation of transcription, DNA-templated GO:0045892 9.72 SIX1 SIX5 TFAP2A TGFB1 TP63
6 sensory perception of sound GO:0007605 9.7 EYA1 SIX1 TFAP2A
7 embryonic skeletal system morphogenesis GO:0048704 9.63 EYA1 SIX1
8 inner ear development GO:0048839 9.63 SIX1 TGFB1
9 outflow tract morphogenesis GO:0003151 9.62 EYA1 SIX1
10 branching involved in ureteric bud morphogenesis GO:0001658 9.62 EYA1 SIX1
11 hair follicle development GO:0001942 9.61 HOXC13 TP63
12 embryonic cranial skeleton morphogenesis GO:0048701 9.61 SIX1 TFAP2A
13 positive regulation of bone mineralization GO:0030501 9.6 TFAP2A TGFB1
14 embryonic forelimb morphogenesis GO:0035115 9.59 TFAP2A TP63
15 regulation of neuron differentiation GO:0045664 9.58 EYA1 SIX1
16 pattern specification process GO:0007389 9.58 EYA1 SIX1 TP63
17 cochlea morphogenesis GO:0090103 9.57 EYA1 SIX1
18 middle ear morphogenesis GO:0042474 9.56 EYA1 SIX1
19 positive regulation of branching involved in ureteric bud morphogenesis GO:0090190 9.55 SIX1 TGFB1
20 pharyngeal system development GO:0060037 9.54 EYA1 SIX1
21 inner ear morphogenesis GO:0042472 9.54 EYA1 SIX1 TFAP2A
22 neuron fate specification GO:0048665 9.51 EYA1 SIX1
23 aorta morphogenesis GO:0035909 9.49 EYA1 SIX1
24 otic vesicle development GO:0071599 9.48 EYA1 SIX1
25 ureteric bud development GO:0001657 9.33 EYA1 SIX1 TGFB1
26 positive regulation of secondary heart field cardioblast proliferation GO:0072513 9.26 EYA1 SIX1
27 positive regulation of transcription by RNA polymerase II GO:0045944 9.17 EYA1 HOXC13 SIX1 SIX5 TFAP2A TGFB1
28 anatomical structure development GO:0048856 9.13 EYA1 SIX1 SIX5
29 regulation of transcription, DNA-templated GO:0006355 10.04 HOXC13 SIX1 SIX5 TFAP2A TP63

Molecular functions related to Lacrimal Duct Obstruction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981 9.8 HOXC13 SIX1 SIX5 TFAP2A TP63
2 chromatin binding GO:0003682 9.56 HOXC13 SIX1 TFAP2A TP63
3 transcription regulatory region DNA binding GO:0044212 9.5 SIX1 TFAP2A TP63
4 proximal promoter DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001077 9.46 HOXC13 SIX1 TFAP2A TP63
5 distal enhancer DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001205 9.37 SIX1 SIX5
6 transcription regulatory region sequence-specific DNA binding GO:0000976 9.13 SIX1 SIX5 TFAP2A
7 sequence-specific DNA binding GO:0043565 9.02 HOXC13 SIX1 SIX5 TFAP2A TP63
Sources

Sources for Lacrimal Duct Obstruction

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....